Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity - Concepedia

Concepedia

Publication | Open Access

Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

DOI Full Paper Access

86

Citations

19

References

2009

Year

Daniel P. Walker, Michael P. Zawistoski, Molly A. McGlynn, Jiancheng Li, Daniel W. Kung, Peter C. Bonnette, Amy Baumann, Leonard Buckbinder, Janet A. Houser, Jason Boer,

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistryPharmaceutical ChemistrySignal TransductionBiochemistryMedicineNatural SciencesReceptor Tyrosine KinaseSulfoximine-substituted Trifluoromethylpyrimidine AnalogsPharmacological AgentPharmacotherapyAnti-cancer AgentPharmacologyCell SignalingDrug Discovery

References

	Year	Citations

Page 1

Page 1